IGF1R and renal fibrosis: IGF-1R inhibitor is suggested to decrease mesangial matrix and exapnsion in kidneys [28], alleviate inflammatory response and renal fibrosis [29,30] and stabilize podocyte integrity and reduce glomerular proteinuria in high-glucose-stimulated podocytes under diabetic conditions [31].